Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention

Bibliography

• Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet (1988) 2(8607):349-360.
   PubMed Web of Science ®Google Scholar
• Collaborative overview of randomised trials of antiplatelet therapy. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. (1994) 308(6921):81-106.
   Google Scholar
• MEHTA SR, YUSUF S, PETERS RJ et al.: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI–CURE study. Lancet (2001) 358(9281):527-533.
   PubMed Web of Science ®Google Scholar
• LEON MB, BAIM DS, POPMA JJ et al.: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N. Engl. J. Med. (1998) 339(23):1665-1671.
   PubMed Web of Science ®Google Scholar
• BERTRAND ME, RUPPRECHT HJ, URBAN P, GERSHLICK AH; CLASSICS INVESTIGATORS: Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation (2000) 102(6):624-629.
   PubMed Web of Science ®Google Scholar
• SAVI P, PEREILLO JM, UZABIAGA MF et al.: Identification and biological activity of the active metabolite of clopidogrel. Thromb. Haemost. (2000) 84(5):891-896.
   PubMed Web of Science ®Google Scholar
• SAVI P, LABOURET C, DELESQUE N et al.: P2y(12), a new platelet ADP receptor, target of clopidogrel. Biochem. Biophys. Res. Commun. (2001) 283(2):379-383.
   PubMed Web of Science ®Google Scholar
• STEINHUBL SR, BERGER PB, BRENNAN DM, TOPOL EJ; CREDO INVESTIGATORS: Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention. J. Am. Coll. Cardiol. (2006) 47(5):939-943.
   PubMed Web of Science ®Google Scholar
• SABATINE MS, CANNON CP, GIBSON CM et al.: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N. Engl. J. Med. (2005) 352(12):1179-1189.
   PubMed Web of Science ®Google Scholar
• SABATINE MS, CANNON CP, GIBSON CM et al.: Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI–CLARITY study. JAMA (2005) 294(10):1224-1232.
   PubMed Web of Science ®Google Scholar
• CHEN ZM, JIANG LX, CHEN YP et al.: Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet (2005) 366(9497):1607-1621.
   PubMed Web of Science ®Google Scholar
• ROGERS WJ, CANTO JG, LAMBREW CT et al.: Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J. Am. Coll. Cardiol. (2000) 36(7):2056-2063.
   PubMed Web of Science ®Google Scholar
• STEINHUBL SR, BERGER PB, MANN JT, 3RD et al.: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 288(19):2411-2420.
   PubMed Web of Science ®Google Scholar
• MULLER I, SEYFARTH M, RUDIGER S et al.: Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart (2001) 85(1):92-93.
   PubMed Web of Science ®Google Scholar
• VON BECKERATH N, TAUBERT D, POGATSA-MURRAY G et al.: Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR–CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) trial. Circulation (2005) 112(19):2946-2950.
   PubMed Web of Science ®Google Scholar
• KASTRATI A, MEHILLI J, SCHUHLEN H et al.: A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N. Engl. J. Med. (2004) 350(3):232-238.
   PubMed Web of Science ®Google Scholar
• MOLITERNO DJ, STEINHUBL SR: Clopidogrel for percutaneous coronary revascularization: time for more pretreatment, retreatment, or both? JAMA (2005) 294(10):1271-1273.
   PubMed Web of Science ®Google Scholar
• KASTRATI A, VON BECKERATH N, JOOST A et al.: Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy. Circulation (2004) 110(14):1916-1919.
   PubMed Web of Science ®Google Scholar
• THE GUSTO ANGIOGRAPHIC INVESTIGATORS: The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N. Engl. J. Med. (1993) 329(22):1615-1622.
   PubMed Web of Science ®Google Scholar
• TOPOL EJ: Acute myocardial infarction: thrombolysis. Heart (2000) 83(1):122-126.
   PubMed Web of Science ®Google Scholar
• BHATT DL, FOX KA, HACKE W et al.: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N. Engl. J. Med. (2006) 354(16):1706-1717.
   PubMed Web of Science ®Google Scholar